<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">kpccz</journal-id><journal-title-group><journal-title xml:lang="ru">Комплексные проблемы сердечно-сосудистых заболеваний</journal-title><trans-title-group xml:lang="en"><trans-title>Complex Issues of Cardiovascular Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2306-1278</issn><issn pub-type="epub">2587-9537</issn><publisher><publisher-name>Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17802/2306-1278-2024-13-4-13-150-158</article-id><article-id custom-type="elpub" pub-id-type="custom">kpccz-1073</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОНЛАЙН. ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ. Кардиология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ONLINE. ORIGINAL STUDIES. CARDIOLOGY</subject></subj-group></article-categories><title-group><article-title>ВЗАИМОСВЯЗЬ ГЕПАТОРЕНАЛЬНОГО ИНДЕКСА И ЭХОГЕННОСТИ КАРОТИДНЫХ АТЕРОСКЛЕРОТИЧЕСКИХ БЛЯШЕК ПО ДАННЫМ GSM-АНАЛИЗА У ПАЦИЕНТОВ С БЕССИМПТОМНЫМ АТЕРОСКЛЕРОЗОМ СОННЫХ АРТЕРИЙ</article-title><trans-title-group xml:lang="en"><trans-title>RELATIONSHIP BETWEEN HEPATORENAL INDEX AND ECHOGENICITY OF CAROTID ATHEROSCLEROTIC PLAQUES ACCORDING TO GSM-ANALYSIS IN PATIENTS WITH ASYMPTOMATIC CAROTID ATHEROSCLEROSIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1136-7284</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузнецова</surname><given-names>Алла Сергеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Kuznetsova</surname><given-names>Alla S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук доцент кафедры госпитальной терапии федерального государственного бюджетного образовательного учреждения высшего образования «Южно-Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации, Челябинск, Российская Федерация</p></bio><bio xml:lang="en"><p>РhD, Assistant at the Department of Advanced Therapy, Federal State Budgetary Educational Institution of Higher Education “South Ural State Medical University”, Chelyabinsk, Russian Federation</p></bio><email xlink:type="simple">kuzja321@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2569-1699</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Долгушина</surname><given-names>Анастасия Ильинична</given-names></name><name name-style="western" xml:lang="en"><surname>Dolgushina</surname><given-names>Anastasia I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук заведующая кафедрой госпитальной терапии федерального государственного бюджетного образовательного учреждения высшего образования «Южно-Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации, Челябинск, Российская Федерация</p></bio><bio xml:lang="en"><p>MD, PhD, Head of the Department of Advanced Therapy, Federal State Budgetary Educational Institution of Higher Education “South Ural State Medical University”, Chelyabinsk, Russian Federation</p></bio><email xlink:type="simple">dolgushinaai@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5902-3803</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Генкель</surname><given-names>Вадим Викторович</given-names></name><name name-style="western" xml:lang="en"><surname>Genkel</surname><given-names>Vadim V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук доцент кафедры пропедевтики внутренних болезней федерального государственного бюджетного образовательного учреждения высшего образования «Южно-Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации, Челябинск, Российская Федерация</p></bio><bio xml:lang="en"><p>PhD, Assistant of the Department of Propaedeutics of Internal Medicine, Federal State Budgetary Educational Institution of Higher Education “South Ural State Medical University”, Chelyabinsk, Russian Federation</p></bio><email xlink:type="simple">henkel-07@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федеральное государственное бюджетное образовательное учреждение высшего образования «Южно-Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации<country>Россия</country></aff><aff xml:lang="en">Federal State Budgetary Educational Institution of Higher Education “South Ural State Medical University”<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>11</day><month>01</month><year>2025</year></pub-date><volume>13</volume><issue>4</issue><fpage>150</fpage><lpage>158</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кузнецова А.С., Долгушина А.И., Генкель В.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Кузнецова А.С., Долгушина А.И., Генкель В.В.</copyright-holder><copyright-holder xml:lang="en">Kuznetsova A.S., Dolgushina A.I., Genkel V.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nii-kpssz.com/jour/article/view/1073">https://www.nii-kpssz.com/jour/article/view/1073</self-uri><abstract><sec><title>Основные положения</title><p>Основные положения </p></sec><sec><title> </title><p> </p></sec><sec><title>Аннотация</title><p>Аннотация</p></sec><sec><title>Цель</title><p>Цель. Изучить взаимосвязь гепаторенального индекса (ГРИ) и эхогенности каротидных атеросклеротических бляшек (АСБ).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Участниками исследования были пациенты с факторами риска сердечно-сосудистых заболеваний. Возраст больных составил 40–64 года. Ультразвуковое исследование брахиоцефальных артерий проведено в стандартных режимах. Эхогенность АСБ в сонных артериях оценена методом GSM-анализа. ГРИ определен как отношение медианы серой шкалы печени к медиане серой шкалы почки. Определение выраженности стеатоза печени выполнено полуколичественным методом с использованием шкалы Hamaguchi.</p></sec><sec><title>Результаты</title><p>Результаты. По единому протоколу обследованы 139 пациентов, среди которых в анализ были включены 104. При оценке наличия связи между эхогенностью каротидных АСБ и показателем по шкале Hamaguchi, с одной стороны, и ГРИ, с другой, выявлены обратные статистически значимые корреляционные связи. Медиана значений GSM каротидных АСБ в исследуемой группе составила 57,0 (39,7; 80,0) усл. ед. С целью установления потенциальной диагностической ценности шкалы Hamaguchi и ГРИ в отношении выявления каротидных АСБ, имеющих эхогенность менее медианных для данной группы пациентов значений, проведен ROC-анализ. По данным логистического регрессионного анализа с поправкой на пол, возраст, ожирение, абдоминальное ожирение увеличение ГРИ более 1,34 ассоциировано с увеличением отношения шансов наличия каротидных АСБ с GSM &lt; 57 усл. ед. (меньше 50 перцентиля) в 2,66 раза (95% ДИ 1,09–6,45; p = 0,031), АСБ с GSM &lt; 39,7 усл. ед. (меньше 25 перцентиля) в 2,95 раза (95% ДИ 1,08–8,08; p = 0,035).</p></sec><sec><title>Заключение</title><p>Заключение. У пациентов среднего возраста с каротидным атеросклерозом выраженность стеатоза печени, оцениваемая по шкале Hamaguchi и количественному определению ГРИ, обратно коррелировала с эхогенностью каротидных АСБ. Увеличение ГРИ &gt; 1,34 с вероятностью 65,8% позволяло прогнозировать наличие каротидных АСБ с GSM менее 57. Отношение шансов наличия каротидных АСБ с GSM &lt; 57 усл. ед. (меньше 50 перцентиля) и GSM &lt; 39,7 усл. ед. (меньше 25 перцентиля) при значениях ГРИ &gt; 1,34 составило 2,66 и 2,95 соответственно после поправки на вмешивающиеся факторы.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Highlights</title><p>Highlights</p></sec><sec><title> </title><p> </p></sec><sec><title>Annotation</title><p>Annotation</p></sec><sec><title>Aim</title><p>Aim. To study the relationship between hepatorenal index (HRI) and echogenicity of carotid atherosclerotic plaques (CAP).</p></sec><sec><title>Methods</title><p>Methods. The study included patients with CVD risk factors. The patients' age ranged from 40 to 64 years. The ultrasound study of the brachiocephalic arteries was carried out in standard modes. Echogenicity of CAP in carotid arteries was assessed by GSM-analysis. HRI was defined as the ratio of the median gray scale of the liver to the median gray scale of the kidney. Severity of hepatic steatosis was determined by semiquantitative method using Hamaguchi scale.</p></sec><sec><title>Results</title><p>Results. 139 patients underwent examination according to a unified protocol. Among those patients 104 were selected for the analysis. Assessing the relationship between echogenicity of carotid CAPs, Hamaguchi scale score and HRI, we have found inverse statistically significant correlations. The median GSM of CAP in the study group was 57,0 (39,7; 80,0) conventional units. In order to determine the potential diagnostic value of Hamaguchi scale and HRI for detecting CAPs with lower than median echogenicity for the given group of patients, we performed ROC analysis. According to logistic regression analysis adjusted for sex, age, obesity, and abdominal obesity, an increase in HRI greater than 1,34 was associated with increased odds ratio of carotid CAPs with GSM &lt; 57 conventional units (less than 50th percentile) by a factor of 2,66 (95% CI 1,09–6,45; p = 0,031), whereas the increase associated with CAPs with GSM &lt; 39,7 conventional units (less than 25th  percentile) was 2,95-fold (95% CI 1,08–8,08; p = 0,035).</p></sec><sec><title>Conclusion</title><p>Conclusion. The severity of hepatic steatosis as assessed by the Hamaguchi scale and HRI was inversely correlated with the echogenicity of carotid CAPs in middle-aged patients with carotid atherosclerosis. An increase in HRI &gt; 1,34 with 65,8% probability predicted the presence of carotid CAPs with a GSM of less than 57. Odds ratio of carotid CAPs with GSM &lt; 57 conventional units (less than the 50th percentile) and GSM &lt; 39,7 (less than 25th percentile) with HRI values &gt; 1,34 were 2,66 and 2,95, respectively, after adjustment for intervening factors.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>Гепаторенальный индекс</kwd><kwd>Стеатоз печени</kwd><kwd>Эхогенность атеросклеротических бляшек</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Hepatorenal index</kwd><kwd>Hepatic steatosis</kwd><kwd>Echogenicity of atherosclerotic plaques</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Авторы заявляют об отсутствии финансирования исследования.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Veracruz N., Hameed B., Saab S., Wong R.J. The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers. J Clin Exp Hepatol. 2021;11(1):45-81. doi: 10.1016/j.jceh.2020.04.018.</mixed-citation><mixed-citation xml:lang="en">Veracruz N., Hameed B., Saab S., Wong R.J. The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers. J Clin Exp Hepatol. 2021;11(1):45-81. doi: 10.1016/j.jceh.2020.04.018.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Simon T.G., Roelstraete B., Hagström H., Sundström J., Ludvigsson J.F. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut. 2022;71(9):1867-1875.. doi: 10.1136/gutjnl-2021-325724.</mixed-citation><mixed-citation xml:lang="en">Simon T.G., Roelstraete B., Hagström H., Sundström J., Ludvigsson J.F. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut. 2022;71(9):1867-1875.. doi: 10.1136/gutjnl-2021-325724.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Pais R., Giral P., Khan J.F., Rosenbaum D., Housset C., Poynard T., Ratziu V.; LIDO Study Group. Fatty liver is an independent predictor of early carotid atherosclerosis. J Hepatol. 2016;65(1):95-102. doi: 10.1016/j.jhep.2016.02.023.</mixed-citation><mixed-citation xml:lang="en">Pais R., Giral P., Khan J.F., Rosenbaum D., Housset C., Poynard T., Ratziu V.; LIDO Study Group. Fatty liver is an independent predictor of early carotid atherosclerosis. J Hepatol. 2016;65(1):95-102. doi: 10.1016/j.jhep.2016.02.023.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Tang A.S.P., Chan K.E., Quek J., Xiao J., Tay P., Teng M., Lee K.S., Lin S.Y., Myint M.Z., Tan B., Sharma V.K., Tan D.J.H., Lim W.H., Kaewdech A., Huang D., Chew N.W., Siddiqui M.S., Sanyal A.J., Muthiah M., Ng C.H. Non-alcoholic fatty liver disease increases Risk of Carotid Atherosclerosis and Ischemic Stroke. An Updated Meta-Analysis with 135,602 Individuals. Clin Mol Hepatol. 2022;28(3):483-496. doi: 10.3350/cmh.2021.0406.</mixed-citation><mixed-citation xml:lang="en">Tang A.S.P., Chan K.E., Quek J., Xiao J., Tay P., Teng M., Lee K.S., Lin S.Y., Myint M.Z., Tan B., Sharma V.K., Tan D.J.H., Lim W.H., Kaewdech A., Huang D., Chew N.W., Siddiqui M.S., Sanyal A.J., Muthiah M., Ng C.H. Non-alcoholic fatty liver disease increases Risk of Carotid Atherosclerosis and Ischemic Stroke. An Updated Meta-Analysis with 135,602 Individuals. Clin Mol Hepatol. 2022;28(3):483-496. doi: 10.3350/cmh.2021.0406.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Генкель В.В., Кузнецова А.С., Лебедев Е.В., Шапошник И.И. Факторы, связанные с эхогенностью атеросклеротических бляшек, у пациентов в возрасте 40-64 лет с каротидным атеросклерозом. Кардиология. 2021;61(6):35-40. doi: 10.18087/cardio.2021.6.n1536.</mixed-citation><mixed-citation xml:lang="en">Genkel V.V., Kuznetsova A.S., Lebedev E.V., Shaposhnik I.I. Factors associated with echogenicity of atherosclerotic plaques in patients aged 40-64 years with carotid atherosclerosis. Cardiology. 2021;61(6):35-40. doi: 10.18087/cardio.2021.6.n1536. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cloutier G., Cardinal M.R., Ju Y., Giroux M.F., Lanthier S., Soulez G. Carotid Plaque Vulnerability Assessment Using Ultrasound Elastography and Echogenicity Analysis. AJR Am J Roentgenol. 2018;211(4):847-855. doi: 10.2214/AJR.17.192</mixed-citation><mixed-citation xml:lang="en">Cloutier G., Cardinal M.R., Ju Y., Giroux M.F., Lanthier S., Soulez G. Carotid Plaque Vulnerability Assessment Using Ultrasound Elastography and Echogenicity Analysis. AJR Am J Roentgenol. 2018;211(4):847-855. doi: 10.2214/AJR.17.192</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Loomba R., Wong R., Fraysse J., Shreay S., Li S., Harrison S., Gordon S.C. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. Aliment Pharmacol Ther. 2020;51(11):1149-1159. doi: 10.1111/apt.15679.</mixed-citation><mixed-citation xml:lang="en">Loomba R., Wong R., Fraysse J., Shreay S., Li S., Harrison S., Gordon S.C. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. Aliment Pharmacol Ther. 2020;51(11):1149-1159. doi: 10.1111/apt.15679.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Брель Н.К., Груздева О.В., Коков А.Н., Масенко В.Л., Дылева Ю.А., Белик Е.В., Барбараш О.Л. Взаимосвязь висцерального ожирения и коронарного кальциноза при ишемической болезни сердца. Терапевтический архив. 2021;93(12):1428-1434. doi: 10.26442/00403660.2021.12.201277</mixed-citation><mixed-citation xml:lang="en">Brel N.K., Gruzdeva O.V., Kokov A.N., Masenko V.L., Dyleva Yu.A., Belik E.V., Barbarash O.L. Interrelation of visceral obesity and coronary calcinosis in ischemic heart disease. Therapeutic Archives. 2021;93(12):1428-1434. doi: 10.26442/00403660.2021.12.201277 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Гарбузенко Д.В., Белов Д.В. Неалкогольная жировая болезнь печени как независимый фактор кардиометаболического риска сердечно-сосудистых заболеваний. Экспериментальная и клиническая гастроэнтерология. 2021;10 (194):22-34. doi: 10.31146/1682-8658-ecg-194-10-22-34</mixed-citation><mixed-citation xml:lang="en">Garbuzenko D.V., Belov D.V. Nonalcoholic fatty liver disease as an independent factor of cardiometabolic risk of cardiovascular disease. Experimental and Clinical Gastroenterology. 2021;10 (194):22-34. doi: 10.31146/1682-8658-ecg-194-10-22-34 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lauridsen B.K., Stender S., Kristensen T.S., Kofoed K.F., Køber L., Nordestgaard B.G., Tybjærg-Hansen A. Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals. Eur Heart J. 2018;39(5):385-393. doi: 10.1093/eurheartj/ehx662.</mixed-citation><mixed-citation xml:lang="en">Lauridsen B.K., Stender S., Kristensen T.S., Kofoed K.F., Køber L., Nordestgaard B.G., Tybjærg-Hansen A. Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals. Eur Heart J. 2018;39(5):385-393. doi: 10.1093/eurheartj/ehx662.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Chandrasekharan K., Alazawi W. Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy? Front Pharmacol. 2020;10:1413. doi: 10.3389/fphar.2019.01413.</mixed-citation><mixed-citation xml:lang="en">Chandrasekharan K., Alazawi W. Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy? Front Pharmacol. 2020;10:1413. doi: 10.3389/fphar.2019.01413.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wu M., Zha M., Lv Q., Xie Y., Yuan K., Zhang X., Liu X. Non-alcoholic fatty liver disease and stroke: A Mendelian randomization study. Eur J Neurol. 2022;29(5):1534-1537. doi: 10.1111/ene.15277.</mixed-citation><mixed-citation xml:lang="en">Wu M., Zha M., Lv Q., Xie Y., Yuan K., Zhang X., Liu X. Non-alcoholic fatty liver disease and stroke: A Mendelian randomization study. Eur J Neurol. 2022;29(5):1534-1537. doi: 10.1111/ene.15277.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Chiriac S., Stanciu C., Girleanu I., Cojocariu C., Sfarti C., Singeap A.M., Cuciureanu T., Huiban L., Muzica C.M., Zenovia S., Nastasa R., Trifan A. Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter. Can J Gastroenterol Hepatol. 2021;2021:6696857. doi: 10.1155/2021/6696857.</mixed-citation><mixed-citation xml:lang="en">Chiriac S., Stanciu C., Girleanu I., Cojocariu C., Sfarti C., Singeap A.M., Cuciureanu T., Huiban L., Muzica C.M., Zenovia S., Nastasa R., Trifan A. Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter. Can J Gastroenterol Hepatol. 2021;2021:6696857. doi: 10.1155/2021/6696857.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zhan R., Qi R., Huang S., Lu Y., Wang X., Jiang J., Ruan X., Song A. The correlation between hepatic fat fraction evaluated by dual-energy computed tomography and high-risk coronary plaques in patients with non-alcoholic fatty liver disease. Jpn J Radiol. 2021;39(8):763-773. doi: 10.1007/s11604-021-01113-9.</mixed-citation><mixed-citation xml:lang="en">Zhan R., Qi R., Huang S., Lu Y., Wang X., Jiang J., Ruan X., Song A. The correlation between hepatic fat fraction evaluated by dual-energy computed tomography and high-risk coronary plaques in patients with non-alcoholic fatty liver disease. Jpn J Radiol. 2021;39(8):763-773. doi: 10.1007/s11604-021-01113-9.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Park H.E., Lee H., Choi S.Y., Kwak M.S., Yang J.I., Yim J.Y., Chung G.E. Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter. J Gastroenterol. 2019;54(3):271-280. doi: 10.1007/s00535-018-1516-5.</mixed-citation><mixed-citation xml:lang="en">Park H.E., Lee H., Choi S.Y., Kwak M.S., Yang J.I., Yim J.Y., Chung G.E. Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter. J Gastroenterol. 2019;54(3):271-280. doi: 10.1007/s00535-018-1516-5.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kweon Y.N., Ko H.J., Kim A.S., Choi H.I., Song J.E., Park J.Y., Kim S.M., Hong H.E., Min K.J. Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems. Healthcare (Basel). 2021;9(7):899. doi: 10.3390/healthcare9070899.</mixed-citation><mixed-citation xml:lang="en">Kweon Y.N., Ko H.J., Kim A.S., Choi H.I., Song J.E., Park J.Y., Kim S.M., Hong H.E., Min K.J. Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems. Healthcare (Basel). 2021;9(7):899. doi: 10.3390/healthcare9070899.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson S.I., Fort D., Shortt K.J., Therapondos G., Galliano G.E., Nguyen T., Bluth E.I. Ultrasound Stratification of Hepatic Steatosis Using Hepatorenal Index. Diagnostics (Basel). 2021;11(8):1443. doi: 10.3390/diagnostics11081443.</mixed-citation><mixed-citation xml:lang="en">Johnson S.I., Fort D., Shortt K.J., Therapondos G., Galliano G.E., Nguyen T., Bluth E.I. Ultrasound Stratification of Hepatic Steatosis Using Hepatorenal Index. Diagnostics (Basel). 2021;11(8):1443. doi: 10.3390/diagnostics11081443.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Sprynger M., Rigo F., Moonen M., Aboyans V., Edvardsen T., de Alcantara M.L., Brodmann M., Naka K.K., Kownator S., Simova I., Vlachopoulos C., Wautrecht J.C., Lancellotti P.; EACVI Scientific Documents Committee. Focus on echovascular imaging assessment of arterial disease: complement to the ESC guidelines (PARTIM 1) in collaboration with the Working Group on Aorta and Peripheral Vascular Diseases. Eur Heart J Cardiovasc Imaging. 2018;19(11):1195-1221. doi: 10.1093/ehjci/jey103.</mixed-citation><mixed-citation xml:lang="en">Sprynger M., Rigo F., Moonen M., Aboyans V., Edvardsen T., de Alcantara M.L., Brodmann M., Naka K.K., Kownator S., Simova I., Vlachopoulos C., Wautrecht J.C., Lancellotti P.; EACVI Scientific Documents Committee. Focus on echovascular imaging assessment of arterial disease: complement to the ESC guidelines (PARTIM 1) in collaboration with the Working Group on Aorta and Peripheral Vascular Diseases. Eur Heart J Cardiovasc Imaging. 2018;19(11):1195-1221. doi: 10.1093/ehjci/jey103.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Marshall R.H., Eissa M., Bluth E.I., Gulotta P.M., Davis N.K. Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis. AJR Am J Roentgenol. 2012;199(5):997-1002. doi: 10.2214/AJR.11.6677.</mixed-citation><mixed-citation xml:lang="en">Marshall R.H., Eissa M., Bluth E.I., Gulotta P.M., Davis N.K. Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis. AJR Am J Roentgenol. 2012;199(5):997-1002. doi: 10.2214/AJR.11.6677.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Tanpowpong N., Panichyawat S. Comparison of sonographic hepatorenal ratio and the degree of hepatic steatosis in magnetic resonance imaging-proton density fat fraction. J Ultrason. 2020;20(82):e169-e175. doi: 10.15557/JoU.2020.0028.</mixed-citation><mixed-citation xml:lang="en">Tanpowpong N., Panichyawat S. Comparison of sonographic hepatorenal ratio and the degree of hepatic steatosis in magnetic resonance imaging-proton density fat fraction. J Ultrason. 2020;20(82):e169-e175. doi: 10.15557/JoU.2020.0028.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hamaguchi M., Kojima T., Itoh Y., Harano Y., Fujii K., Nakajima T., Kato T., Takeda N., Okuda J., Ida K., Kawahito Y., Yoshikawa T., Okanoue T. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102(12):2708-15. doi: 10.1111/j.1572-0241.2007.01526.x.</mixed-citation><mixed-citation xml:lang="en">Hamaguchi M., Kojima T., Itoh Y., Harano Y., Fujii K., Nakajima T., Kato T., Takeda N., Okuda J., Ida K., Kawahito Y., Yoshikawa T., Okanoue T. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102(12):2708-15. doi: 10.1111/j.1572-0241.2007.01526.x.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Martín-Rodríguez J.L., Arrebola J.P., Jiménez-Moleón J.J., Olea N., González-Calvin J.L. Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy. Eur J Gastroenterol Hepatol. 2014;26(1):88-94. doi: 10.1097/MEG.0b013e3283650650.</mixed-citation><mixed-citation xml:lang="en">Martín-Rodríguez J.L., Arrebola J.P., Jiménez-Moleón J.J., Olea N., González-Calvin J.L. Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy. Eur J Gastroenterol Hepatol. 2014;26(1):88-94. doi: 10.1097/MEG.0b013e3283650650.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hsiao C.C., Teng P.H., Wu Y.J., Shen Y.W., Mar G.Y., Wu F.Z. Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis. BMC Cardiovasc Disord. 2021;19;21(1):244. doi: 10.1186/s12872-021-02060-z.</mixed-citation><mixed-citation xml:lang="en">Hsiao C.C., Teng P.H., Wu Y.J., Shen Y.W., Mar G.Y., Wu F.Z. Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis. BMC Cardiovasc Disord. 2021;19;21(1):244. doi: 10.1186/s12872-021-02060-z.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hsu P.F., Wang Y.W., Lin C.C., Wang Y.J., Ding Y.Z., Liou T.L., Huang S.S., Lu T.M., Chan W.L., Lin S.J., Leu H.B. The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population. Liver Int. 2021;41(1):81-90. doi: 10.1111/liv.14637.</mixed-citation><mixed-citation xml:lang="en">Hsu P.F., Wang Y.W., Lin C.C., Wang Y.J., Ding Y.Z., Liou T.L., Huang S.S., Lu T.M., Chan W.L., Lin S.J., Leu H.B. The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population. Liver Int. 2021;41(1):81-90. doi: 10.1111/liv.14637.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
